Brief communication
Radiation therapy in endemic (African) Kaposi's sarcoma

https://doi.org/10.1016/0360-3016(93)90541-3Get rights and content

Abstract

Purpose: Evaluating the role of radiation therapy in the treatment of the endemic, African variant of Kaposi's sarcoma. A retrospective analysis.

Methods and Materials: Between 1978 and 1990, 28 symptomatic African patients with the African Human Immunodeficiency Virus negative type of Kaposi's sarcoma were referred to the Johannesburg General Hospital. Following staging, all patients were treated with radiation therapy. Doses ranged between 8–10 Gy (single fraction) or 14–24 Gy fractionated over 1–3 weeks.

Results: Complete and partial regression of cutaneous lesions was achieved in 9 (32%) and 15 (54%) patients, retrospectively. A complete/near-complete alleviation of symptoms was achieved in all patients. Response rate and duration of response was not influenced by age, radiation modality or schedule. Side effects were minimal.

Conclusion: Our study emphasizes the high radiosensitivity of the endemic, African type of Kaposi's sarcoma, indicating its usefulness as the treatment of choice for this disease.

References (21)

There are more references available in the full text version of this article.

Cited by (10)

  • Role of radiation therapy in non-melanoma cancers, lymphomas and sarcomas of the skin: Systematic review and best practice in 2016

    2016, Critical Reviews in Oncology/Hematology
    Citation Excerpt :

    There were local failures in 23% and out-field recurrences in 26%. Stein et al. (1993) evaluated the role of RT in the treatment of the endemic, African variant of Kaposi’s sarcoma. Twenty-eight symptomatic patients were treated with RT at doses ranging between 8 and 10 Gy (single fraction) or 14 and 24 Gy fractionated over 1–3 weeks.

  • Kaposi's sarcoma: Advances and perspectives

    1996, Journal of the American Academy of Dermatology
View all citing articles on Scopus
View full text